Why the Pro Medicus (ASX:PME) share price is climbing today

The Pro Medicus Limited (ASX: PME) share price is climbing today despite the offload of shares by its co-founders. Here's the details.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Pro Medicus Limited (ASX: PME) shares are climbing in morning trade despite the company announcing its co-founders have offloaded a parcel of their shares. At the time of writing, the Pro Medicus share price is up 2.5% to $46.40.

Hands grabbing for high rung on a ladder pointing to the sky

Image source: Getty Images

Co-founders sell shares

The Pro Medicus share price is on the rise regardless of the fact the health imaging company reported its co-founders have sold off a portion of their stake in the business.

According to this morning's release, Pro Medicus co-founders Dr Sam Hupert and Mr Anthony Hall have each sold 1 million shares. The sale transacted at market close yesterday (18 February) at the price of $45.97 per share.

Pro Medius noted that the offload of shares by the co-founders represents less than 4% of their entire individual holdings. Dr Sam Hupert and Mr Anthony Hall now have 27,137,660 and 27,109,000 ordinary shares respectively after the change.

The company stated that both co-founders do not intend to sell further shares in the foreseeable future.

Words from the chair

Pro Medicus chair Peter Kempen commented on the sale of the shares:

We announced in February 2018 that the Board had encouraged the founders to consider selling up to 3 million shares each, in order to improve the liquidity in the company's shares. This latest transaction completes that process. The sale, to a number of local institutions, was done "at market" which reflects the very strong underlying demand for the company's shares.

Mr Kempen added:

Dr Hupert and Mr Hall remain actively engaged in the company and are committed to its future. This is evidenced by the fact that they remain the two key stake holders, with their combined holding post this recent sale being in excess of 52% of the shares on issue.

Pro Medicus share price snapshot

The Pro Medicus share price has been a stellar performer over the past 12 months, jumping by more than 100%. Pro Medicus shares hit a 52-week low of $14.50 in March before accelerating to an all-time high of $47.62 this week.

At the current share price of $46.60, Pro Medicus is a whisker away from breaking that feat again.

Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and recommends Pro Medicus Ltd. The Motley Fool Australia has recommended Pro Medicus Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Share Market News

Testing again

Read more »

Share Market News

Aaron Test 2

Read more »

Share Market News

Aaron Test

Read more »

Share Market News

JP Test

Read more »

Share Market News

JP Test

Read more »

Portrait of Discovery Fund portfolio managers Mark Devcich and Chris Bainbridge
Share Market News

Test

Portfolio managers Mark Devcich (left) and Chris Bainbridge. Image source: Discovery Fund test test

Read more »

a man in a hoodie grins slyly as he sits with his hands poised on a keyboard. He is superimposed with a graphic image of a computer screen asking for a password, suggesting he is a hacker.
Share Market News

Another ASX 200 company has been hit with a cyber incident. Here's what we know

Hackers have breached the systems of this ASX 200 company.

Read more »

a woman
Broker Notes

5 ASX 200 shares that inflation can't touch: expert

Regardless of whether you're a bull or a bear, cost pressures are a factor when buying stocks at the moment.

Read more »